News

Targeted therapy for children with leukemia can provide substantial benefit, study finds

Genomic testing of patient leukemia cells uncovers genetic alterations that can be targeted by drug therapies in many patients.

Stuart H. Orkin Receives the 2021 ISSCR Tobias Lecture Award

Established in 2015 and supported by the Tobias Foundation, the prize recognizes original and promising basic hematology research as well as direct translational or clinical research related to cell therapy in hematological disorders.

In landmark study, an arthritis drug appears to prevent deadly acute graft-versus-host disease after bone marrow transplant

Abatacept (Orencia) reduces rates of acute GVHD, boosts survival in Phase 2 multicenter trial.

Dana-Farber/Boston Children's Faculty Named 2021 Top Doctors

Boston magazine has named a number of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center faculty members to its annual "Top Doctors" guide.